Estimating the duration of RT-PCR positivity for SARS-CoV-2 from doubly interval censored data with undetected infections
Biometrics · 07.10.2026 · 82 (4)
DOI: 10.1093/biomtc/ujag162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, online erschienen am 17.11.2026. Verfasst von Joshua Blake und 7 weiteren Autor:innen. Beteiligte Einrichtung: MRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Reverse Transcriptase Polymerase Chain Reaction. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Medical Research Council, National Institute for Health Research, Health Protection Research Unit.
Abstract (Originalsprache)
Monitoring the incidence of new infections during a pandemic is critical for an effective public health response. General population prevalence surveys for SARS-CoV-2 can provide high-quality data to estimate incidence. However, estimation relies on understanding the distribution of the duration that infections remain detectable. This study addresses this need using data from the Coronavirus Infection Survey (CIS), a long-term, longitudinal, general population survey conducted in the United Kingdom. Analyzing these data presents unique challenges, such as double interval censoring, undetected infections, and false negatives. We propose a Bayesian nonparametric survival analysis approach, estimating a discrete-time distribution of durations and integrating prior information derived from a complementary study. Our methodology is validated through a simulation study, including its resilience to model misspecification, and then applied to the CIS dataset. This results in the first estimate of the full duration distribution in a general population, as well as methodology that could be transferred to new contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, United Kingdom.
- Analytics and Intelligence Assessment, Chief Data Officer Group, UK Health Security Agency, London E14 4PU, United Kingdom.
- Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
- NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, United Kingdom.
- NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, OX3 9DU Oxford, United Kingdom.
- Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG Oxford, United Kingdom.
ORCID-Profile: Joshua Blake, Paul Birrell, Thomas House, Theodore Kypraios
Förderung
- UK Medical Research Council
- National Institute for Health Research
- Health Protection Research Unit
- Oxford University
- NIHR Biomedical Research Centre, Oxford
Zitieren
APA
Blake, J., Birrell, P., Walker, A. S., Pouwels, K. B., House, T., Tom, B. D. M., Kypraios, T., & De Angelis, D. (2026). Estimating the duration of RT-PCR positivity for SARS-CoV-2 from doubly interval censored data with undetected infections. Biometrics, 82(4). https://doi.org/10.1093/biomtc/ujag162
Vancouver
Blake J, Birrell P, Walker AS, Pouwels KB, House T, Tom BDM, et al. Estimating the duration of RT-PCR positivity for SARS-CoV-2 from doubly interval censored data with undetected infections. Biometrics. 2026;82(4). doi:10.1093/biomtc/ujag162
BibTeX
@article{Blake2026,
author = {Blake, Joshua and Birrell, Paul and Walker, A Sarah and Pouwels, Koen B and House, Thomas and Tom, Brian D M and Kypraios, Theodore and De Angelis, Daniela},
title = {Estimating the duration of RT-PCR positivity for SARS-CoV-2 from doubly interval censored data with undetected infections},
journal = {Biometrics},
year = {2026},
volume = {82},
number = {4},
doi = {10.1093/biomtc/ujag162}
}
EUVIMED